Expertise in
2
conditions
Expertise in
2
conditions
Baarn, UT, NL 

Overview

Anke Lanser practices practicing medicine in Baarn, Netherlands.

Ms. Lanser is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Facioscapulohumeral Muscular Dystrophy (FSHD), Moebius Syndrome, Bell's Palsy, and Charlie M Syndrome.

She is actively involved in clinical research, co-authoring 8 peer reviewed articles.

Gender

Female

Locations

Baarn, UT, Netherlands
Other Locations
Wassenaar, ZH, Netherlands

Frequently Asked Questions about Anke Lanser

Is Anke Lanser a top-rated expert for Facioscapulohumeral Muscular Dystrophy (FSHD)?

MediFind is an objective health platform that identifies experts based on real-world data. Anke Lanser is classified as an Advanced expert for Facioscapulohumeral Muscular Dystrophy (FSHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Anke Lanser participate in research or clinical trials?

Yes. Anke Lanser has published 8 articles and abstracts on conditions like Facioscapulohumeral Muscular Dystrophy (FSHD). You can view a list of Anke Lanser's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lanser's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile